ReviewACS omega2026
Advancing Membrane Technologies for Cancer Therapy and Environmental Health: Biomimetic Innovations, Smart Technologies, and Sustainable Translation.
Review in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Biomimetic and advanced membrane technologies are emerging as powerful platforms bridging biomedical and environmental applications, particularly in cancer therapy and water purification. However, current research remains fragmented, with limited integration of design principles across these domains. This review addresses this gap by presenting a unified analytical framework to systematically evaluate diverse membrane systems, including biomimetic nanoparticle membranes, exosome-based membranes, implantable devices, ultrathin functional membranes, graphene/2D membranes, and more. We comparatively assess their structural features, functional performance, industrial and clinical maturity, and scalability to highlight their complementary roles in targeted drug delivery, biosensing, and contaminant removal. Emphasis is placed on translational challenges, including manufacturing complexity, standardization, and regulatory constraints. Furthermore, emerging strategies such as AI-driven design, hybrid membrane engineering, and sensing-separation integration are critically examined as pathways to enhance performance and real-world applicability. This work provides a coherent foundation for cross-disciplinary innovation and supports the development of scalable, high-performance membrane systems for precision medicine and sustainable environmental technologies.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.